Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US
Condition: Meningococcal Infections Interventions: Biological: MenACYW conjugate vaccine; Biological: MenACYW-135 conjugate vaccine; Biological: DTaP-IPV//Hib vaccine; Biological: Pneumococcal 13-valent conjugate vaccine; Biological: Pentavalent rotavirus vaccine; Biological: Hepatitis B vaccine; Biological: Meas les, mumps, rubella (MMR) vaccine; Biological: Varicella vaccine; Biological: Hepatitis A vaccine Sponsor: Sanofi Pasteur, a Sanofi Company Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Men | Meningitis | Meningitis Vaccine | Mumps | Mumps Vaccine | Pediatrics | Pneomococcal Vaccine | Tetanus Diptheria Pertussis Vaccine Tdap,Dtap,Dpt | Vaccines